Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Early access programs: Benefits, challenges, and key considerations for successful implementation
by
Patil, Sanjaykumar
in
Access to information
/ Clinical trials
/ Conflicts of interest
/ Descriptive labeling
/ Drugs
/ Early access programs, named patient programs, patients with life-threatening diseases
/ Ebola virus
/ Epidemics
/ FDA approval
/ Federal regulation
/ Methods
/ Pharmaceutical industry
/ Pharmaceutical research
/ Product development
/ Regulatory approval
/ Review
/ Social networks
2016
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Early access programs: Benefits, challenges, and key considerations for successful implementation
by
Patil, Sanjaykumar
in
Access to information
/ Clinical trials
/ Conflicts of interest
/ Descriptive labeling
/ Drugs
/ Early access programs, named patient programs, patients with life-threatening diseases
/ Ebola virus
/ Epidemics
/ FDA approval
/ Federal regulation
/ Methods
/ Pharmaceutical industry
/ Pharmaceutical research
/ Product development
/ Regulatory approval
/ Review
/ Social networks
2016
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Early access programs: Benefits, challenges, and key considerations for successful implementation
by
Patil, Sanjaykumar
in
Access to information
/ Clinical trials
/ Conflicts of interest
/ Descriptive labeling
/ Drugs
/ Early access programs, named patient programs, patients with life-threatening diseases
/ Ebola virus
/ Epidemics
/ FDA approval
/ Federal regulation
/ Methods
/ Pharmaceutical industry
/ Pharmaceutical research
/ Product development
/ Regulatory approval
/ Review
/ Social networks
2016
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Early access programs: Benefits, challenges, and key considerations for successful implementation
Journal Article
Early access programs: Benefits, challenges, and key considerations for successful implementation
2016
Request Book From Autostore
and Choose the Collection Method
Overview
Early access programs, (EAPs) are adopted by an increasing number of pharma companies due to several benefits offered by these programs. EAPs offer ethical, compliant, and controlled mechanisms of access to investigational drugs outside of the clinical trial space and before the commercial launch of the drug, to patients with life-threatening diseases having no treatment options available. In addition to the development of positive relationships with key opinion leaders (KOL), patients, advocacy groups and regulators, the data captured from the implementation of EAPs supports in the formulation of global commercialization strategies. This white paper outlines various circumstances to be considered for the implementation of EAPs named patient programs, the regulatory landscape, the benefits and challenges associated with implementing these programs and the key considerations for their successful implementation.
Publisher
Wolters Kluwer - Medknow Publications,Medknow Publications and Media Pvt. Ltd,Medknow Publications & Media Pvt. Ltd,Medknow Publications & Media Pvt Ltd,Wolters Kluwer Medknow Publications
This website uses cookies to ensure you get the best experience on our website.